How an oral immunotherapy treatment is combating superbugs — A Q&A with Immuron’s Jerry Kanellos – Becker’s ASC Review
|
How an oral immunotherapy treatment is combating superbugs — A Q&A with Immuron's Jerry Kanellos
Becker’s ASC Review Victoria, Australia-based Immuron has developed an oral immunotherapy using polyclonal antibody products, in place of antibiotics, to combat superbugs and antibiotic resistant bacteria, and boost the effectiveness of novel treatments. Immuron's Chief … |
